씨티씨바이오

060590KOSDAQ의약품 제조업

43.7 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40

News Sentiment17.2 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is above the industry average but the high debt ratio poses financial risk. Declined 8.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CTC Bio operates in the animal and human pharmaceutical sectors, leveraging core technologies such as microbial fermentation, drug coating, and DDS to develop diverse products. Its key revenue drivers include award-winning products like CTCZYME and ODF films, while the company actively manages foreign exchange risks to strengthen its global competitiveness.

Number of Employees

237people

Average Salary

46.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

27.08Industry Average 14.801.5Point

1.8x industry avg (risky)

PBR

1.23Industry Average 1.042.5Point

Higher than industry avg (caution)

ROE

4.55Industry Average 4.424.0Point

In line with industry avg

Debt Ratio

27.63Industry Average 11.980.0Point

2.3x industry avg (risky)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲135.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.0% (improving, 3yr)

Detailed News Sentiment

8 totalPositive 5Neutral 0Negative 0Average Sentiment Score 80

Positive
[쇼핑 단신] 코스맥스펫, 펫 유산균 시장 본격화 외
씨티씨바이오는 코스맥스펫과 전략적 제조 파트너십을 체결하여 프리미엄 반려동물 유산균 시장 공략을 본격화합니다.
Positive
멍냥이 전용 유산균에 보습 크림… “펫팸族 잡아라” 유통가 경쟁
반려동물 헬스케어 시장의 성장과 함께 씨티씨바이오가 코스맥스펫과의 협력을 통해 펫 유산균 시장을 확대할 것으로 기대됩니다.
Positive
펫팸족 증가에 펫 헬스케어 급성장…유산균·뷰티 시장 확대
펫팸족 증가에 따른 펫 헬스케어 시장의 급성장 속에서 씨티씨바이오가 코스맥스펫과 협력하여 유산균 및 뷰티 시장을 확대할 예정입니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 3,710Won52-week high 7,45052-week low 3,620

1-month return1.0Point

1m -8.85% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral[기재정정]정기주주총회결과2026-03-27
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral본점소재지변경2026-03-26
Neutral정기주주총회결과2026-03-26
Neutral감사보고서제출2026-03-18